Ontozry 12.5 mg, Tabletten - 14 Swissmedic Key 68051001 Registration Holder Angelini Pharma S.p.A., Rom, Zweigniederlassung Zug Name Ontozry 12.5 mg, Tabletten Date of registration 19.05.2022 Introduction of Sequence 19.05.2022 ATC-Classification Cenobamate (N03AX25) Revision date WHO WHO-DDD Valid until 18.05.2027 Index Therapeuticus (BSV) 01.07.10. Show package size 14 Index Therapeuticus (Swissmedic) 01.07.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680680510018 Medication Code Synthetika Pharmacode Disponibility
Composition cenobamatum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 39.67 mg, carboxymethylamylum natricum A corresp. natrium 0.16 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Cenobamatum 12.5 mg
Inactive agents Dose Carboxymethylamylum Natricum A Cellulosum Microcristallinum Lactose Monohydrate 39.67 mg Magnesii Stearas Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 07.02.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
